How Should Covid-19 Surveillance Testing Be Correctly Billed

As the world continues to navigate the challenges presented by the Covid-19 pandemic, Surveillance Testing has become an essential tool in tracking and preventing the spread of the virus. However, the Billing Process for these tests can be complex and confusing. In this article, we will discuss how Covid-19 Surveillance Testing should be correctly billed to ensure accurate Reimbursement and compliance with Regulations.

Understanding Covid-19 Surveillance Testing

Before delving into the Billing Process, it is important to understand what Covid-19 Surveillance Testing entails. Surveillance Testing involves testing individuals who do not have symptoms of Covid-19 but may have been exposed to the virus. This type of testing is crucial in identifying asymptomatic carriers of the virus and preventing outbreaks in communities.

Types of Surveillance Testing

1. Mass testing events
2. Random sampling of a population
3. Testing of specific groups, such as healthcare workers or students

Billing for Covid-19 Surveillance Testing

Properly billing for Covid-19 Surveillance Testing is essential to ensure that Healthcare Providers are adequately reimbursed for their services. Here are some key points to keep in mind when billing for Surveillance Testing:

Use the Correct CPT Codes

When billing for Covid-19 Surveillance Testing, it is important to use the correct Current Procedural Terminology (CPT) codes to accurately describe the services provided. The following CPT codes are commonly used for Covid-19 testing:

1. 87635 - Infectious agent detection by nucleic acid (RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [Covid-19]), amplified probe technique
2. 87636 - Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [Covid-19]), amplified probe technique, including multiplex reverse transcription

Include the Appropriate Diagnosis Codes

When submitting claims for Covid-19 Surveillance Testing, it is important to include the appropriate diagnosis codes to indicate the reason for the testing. The following ICD-10 codes are commonly used for Covid-19 testing:

1. U07.1 - Covid-19
2. Z11.59 - Encounter for screening for other viral diseases

Ensure Compliance with Billing Regulations

It is essential to ensure compliance with billing Regulations when submitting claims for Covid-19 Surveillance Testing. This includes verifying that all necessary documentation is provided, following up on any denials or rejections, and adhering to all coding and billing guidelines set forth by government agencies and insurance companies.

Reimbursement for Covid-19 Surveillance Testing

Reimbursement for Covid-19 Surveillance Testing can vary depending on the type of test performed, the provider's location, and the patient's Insurance Coverage. It is important to stay up-to-date on the latest Reimbursement rates and guidelines to ensure that providers are adequately compensated for their services.

Medicare Reimbursement

Medicare typically reimburses for Covid-19 Surveillance Testing at a rate of $100 per test. Providers who participate in the Medicare program should refer to the Medicare Physician Fee Schedule for current Reimbursement rates and billing guidelines.

Commercial Insurance Reimbursement

Commercial insurance companies may reimburse for Covid-19 Surveillance Testing at varying rates. Providers should verify the Reimbursement rates and requirements with each individual insurance company to ensure accurate billing and Reimbursement.

Conclusion

Covid-19 Surveillance Testing plays a crucial role in monitoring and preventing the spread of the virus in communities. Properly billing for Surveillance Testing is essential to ensure accurate Reimbursement and compliance with Regulations. By using the correct CPT codes, including the appropriate diagnosis codes, and ensuring compliance with billing Regulations, Healthcare Providers can optimize their Reimbursement for Covid-19 Surveillance Testing services.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on phlebotomy practices and healthcare. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.